Clinical Trial Update: Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates the efficacy and safety of valsartan versus placebo on exercise tolerance in patients with diastolic dysfunction and symptomatic he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Heart Failure

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Diastolic Dysfunction, Symptomatic Heart Failure | Phase 4 | Status: COMPLETED